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Abstract
Campylobacter jejuni is a highly diverse enteropathogen that is commonly detected worldwide. It can sometimes cause bacteraemia, but the
bacterial characteristics facilitating bloodstream infection are not known. A total of 73 C. jejuni isolates, consecutively collected from
blood-borne infections during a 10-year period all over Finland and for which detailed clinical information of the patients were available,
were included. We screened the isolates by PCR for the lipooligosaccharide (LOS) locus class and for the presence of the putative virulence
genes ceuE, ciaB, fucP, and virB11. The isolates were also tested for c-glutamyl transpeptidase production. The results were analysed with
respect to the clinical characteristics of the patients, and the multilocus sequence types (MLSTs) and serum resistance of the isolates. LOS
locus classes A, B, and C, which carry genes for sialylation of LOS, were detected in only 23% of the isolates. These isolates were not more
resistant to human serum than those with the genes of non-sialylated LOS locus classes, but were signiﬁcantly more prevalent among
patients with underlying diseases (p 0.02). The fucose permease gene fucP was quite uncommon, but was associated with the isolates with
the potential to sialylate LOS (p <0.0001). LOS locus classes and some of the putative virulence factors were associated with MLST clonal
complexes. Although some of the bacterial characteristics studied here have been suggested to be important for the invasiveness of C. jejuni,
they did not explain why the clinical isolates in the present study were able to cause bacteraemia.
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Introduction
Campylobacter jejuni is one of the most common bacterial
enteropathogens. It causes diarrhoea with fever and abdominal
pain, and in many cases the infection resolves spontaneously
[1,2]. However, complications such as bacteraemia and
post-infection sequelae such as Guillain–Barre syndrome
(GBS) and reactive arthritis may occur [3]. There is an
increasing body of evidence indicating that the structure of
C. jejuni lipooligosaccharide (LOS) might have a role in the
outcome of infection. Sialylated LOS locus classes have been
found more frequently than non-sialylated LOS locus classes in
GBS-associated C. jejuni strains [4]. Furthermore, it has been
reported that C. jejuni strains with sialylated LOS are less
susceptible to normal human serum (NHS) and have a higher
invasion potential in cell cultures, and that inactivation of LOS
sialyltransferase results in the loss of such invasiveness [5–8].
The role of different putative virulence factors in bacterial
adhesion, colonization, invasion, and ultimately, the outcome of
Campylobacter infection has yet to be explained. Campylobacter
invasion antigen (CiaB) and the plasmid pVir are suggested
markers for the virulence potential of C. jejuni [9–11]. In our
study on C. jejuni isolates from enteritis patients [12], the
putative virulence genes ceuE, encoding an enterochelin uptake
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protein [13], and cj0486, recently demonstrated to be a putative
L-fucose permease gene, fucP [14,15], were more prevalent in
isolates of foreign origin, whereas c-glutamyl transpeptidase
(GGT) was associated with infections acquired in Finland.
In a recent nationwide study conducted over a 10-year
period, we collected blood culture isolates of C. jejuni and
Campylobacter coli, clinical features of the corresponding
bacteraemic episodes and characteristics of the patients from
all over Finland [16]. We found that the patients were
moderately young, and mostly without any signiﬁcant under-
lying diseases [16]. We recently characterized these particular
C. jejuni blood culture isolates with respect to their clonal
distribution, by using multilocus sequence typing (MLST), and
to their serum resistance. We found that nearly half of the
isolates belonged to the otherwise uncommon sequence type
(ST) 677 clonal complex (CC) (ST-677 CC) [17]. Isolates
belonging to this particular CC were more resistant to NHS
than the other isolates, but otherwise serum resistance was
not a prerequisite for bacteraemic infection [17]. In the
present study, we further examined bacterial characteristics
that might be important for the ability of C. jejuni to enter the
bloodstream, and used PCR to screen for LOS locus class and
for the presence of the putative virulence genes ceuE, ciaB,
fucP, and virB11. Isolates were also tested for GGT production.
These results were analysed with respect to the clinical
characteristics of the patients, and the MLST types and serum
resistance of the isolates.
Materials and Methods
The bacterial isolates and the patient data were collected as
described previously [16]. Brieﬂy, all patients with known
episodes of C. jejuni or C. coli bacteraemia from the time
period 1998–2007 in Finland, and for whom both the bacterial
isolates and clinical information were available, were included.
The underlying diseases were scored and grouped according
to the Charlson weighted index of comorbidity [18]. Of the 76
patients described earlier, three were excluded because of
C. coli infection.
All except one of the 73 C. jejuni bacteraemia isolates had
been earlier genotyped by MLST [17]. Among the isolates, the
ST-677 CC was the most prevalent (35 isolates, 48%) followed
by the ST-45 CC (12 isolates, 16%) and ST-21 CC (10 isolates,
14%). The ST-48 CC and ST-464 CC were both represented
by two isolates, and six CCs (ST-52, ST-354, ST-443, ST-460,
ST-508, and ST-1332) had one isolate each. Five isolates were
in unassigned STs [17].
Serum sensitivity assay had been performed for 73 isolates
according to methods described previously [5,17,19]. Suscep-
tibility to NHS varied between the C. jejuni isolates belonging
to different CCs, such that isolates of the ST-677 CC were
signiﬁcantly less susceptible, whereas the isolates of the ST-45
CC were signiﬁcantly more susceptible, than all other isolates
[17].
LOS biosynthesis locus classiﬁcation was performed for all
73 C. jejuni isolates by PCR screening, according to Parker
et al. [20,21]. The primers and sequences used are described in
Table 2 of reference [21]. LOS locus classes A and B were
identiﬁed with primers for orf7ab (cstII), orf6ab1 (cgtB-1),
orf6ab2 (cgtB-2), and orf5bII (cgtAII). LOS locus class C was
identiﬁed with primers for orf6c (cgtB) and orf7c (cstIII). LOS
locus classes E/O and H/P were identiﬁed with primers for
orf26e and orf27e. Primers for orf18df were used to attribute
isolates not covered by the above primers. The orf18df-
positive isolates belong to the non-sialylated LOS locus
classes D, F, I, J, K, N, S, or Q [20]. All isolates were positive
for orf12 (waaV).
The presence of the putative virulence genes ceuE, ciaB, fucP
and virB11 was screened for by PCR. The primers used are
listed in Table 2 of reference [12]. The reaction mixture
contained 1 9 AmpliTaq Gold 360 buffer, 1.25 U of AmpliTaq
Gold 360 polymerase (Applied Biosystems, Foster City, CA,
USA), 200 lM dNTP (Fermentas, St. Leon-Rot, Germany),
0.2 lM each primer (Eurogentec, Ougree, Belgium) and 5 lL
of template DNA, in a total volume of 25 lL. Cycling
conditions were as follows: 95°C for 10 min, followed by 25
cycles of 95°C for 30 s, annealing (ceuE, 60°C; virB11, 53°C;
ciaB and cj0486, 58°C) for 30 s, 72°C for 60 s, and ﬁnal
extension at 72°C for 7 min. For virB11, a touch-down
protocol was used, with ﬁve cycles at 53°C, ﬁve cycles at 52°C,
and 15 cycles at 51°C. Qualitative detection of GGT activity
was performed as described previously [12].
Statistical analyses were performed with Graphpad Prism
version 4.03 (Graphpad Software, San Diego, CA, USA) and
PASW Statistics 18 (SPSS, Chicago, IL, USA). The v2-test and
Fisher’s exact test were used for comparison of categorical
variables. The Mann–Whitney test was used for comparison of
continuous variables. All tests were two-sided, and a p-value of
<0.05 was considered to be statistically signiﬁcant.
The study was approved by the Finnish Ministry of Social
Affairs and Health.
Results
In this cohort of 73 patients with C. jejuni bacteraemia, only 17
(23%) of the isolates belonged to LOS locus classes with the
potential to sialylate their LOSs; four to class A1, ﬁve to
class B2, and eight to class C. Of the remaining isolates 38
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belonged to class E/O and 15 to class H/P. Three isolates were
positive for orf18. There was no association between the
isolates harbouring genes for sialylation of LOS and symptoms
of the patients preceding the bacteraemia, but the patients
with underlying diseases (Charlson index of ≥1) had signiﬁ-
cantly more often isolates of LOS locus class A, B, or C,
carrying genes for sialylation of LOS (p 0.02; Table 1). Among
the C. jejuni isolates with the ability to sialylate LOS, those of
locus class C showed further speciﬁc features; patients
infected with isolates of LOS locus class C were hospitalized
for a longer period than those infected with other isolates
(median duration, 19 days vs. 4 days; p 0.005). This ﬁnding
seemed to be LOS locus class-speciﬁc, as no signiﬁcant
difference could be detected in the hospitalization time
between the patients infected with isolates of LOS locus
class A, B or C (analysed as a group) and those infected with
isolates unable to sialylate LOS (Table 1). In addition, the
isolate of the patient who had developed GBS was of LOS
locus class C.
Resistance to NHS was compared between isolates accord-
ing to LOS locus class. There were no signiﬁcant differences in
susceptibility to NHS when the isolates harbouring genes
needed for sialylation of LOS (classes A, B, and C) were
compared with the isolates unable to sialylate LOS (median
bacterial survival in serum, 15% vs. 27%; p 0.28) (Fig. 1).
Although isolates of LOS locus class C were associated with
longer duration of hospitalization, as mentioned above, these
isolates were not more resistant to NHS than other isolates
(p 0.315).
We found associations between LOS locus classes and
MLST clonal complexes. All isolates of the ST-677 CC and of
the ST-45 CC were of LOS locus class E/O or H/P, lacking
genes for sialylation of LOS, whereas all isolates of the ST-21
CC belonged to classes enabling sialylation of LOS, including all
eight isolates of locus class C (Table 1).
The presence of genes encoding putative virulence factors
in the C. jejuni isolates were studied by PCR. The fucP gene,
which is involved in the utilization of L-fucose, was present in
17 (23%) isolates; ceuE, encoding a protein involved in iron
uptake, was present in 71 (97%) isolates; ciaB was present in 73
(100%) isolates; and virB11 of the pVir plasmid was present in
only two (3%) isolates. Production of GGT was detected in 13
(18%) isolates. These isolates predominantly belonged to the
ST-45 CC (83% GGT-positive vs. 5% of all other strains;
p <0.0001), and were signiﬁcantly more sensitive to NHS than
GGT-negative isolates (median bacterial survival in serum,
1.3% vs. 27%; p 0.0002). The fucP gene was signiﬁcantly more
prevalent among isolates with the potential to sialylate LOS
than among those lacking genes for sialylation of LOS
(p <0.0001; Table 1). This gene was also strongly associated
with ST-21 CC isolates (100% fucP-positive vs. 14% of all other
isolates; p <0.0001). Furthermore, fucP-positive isolates were
signiﬁcantly more sensitive to NHS than fucP-negative isolates
(median bacterial survival in serum, 11% vs. 28%; p 0.039). All
35 ST-677 CC isolates were fucP-negative, virB11-negative,
ciaB-positive, GGT-negative, and, except for two isolates, also
ceuE-positive. Of the other isolates, one ST-45 CC isolate and
one ST-21 CC isolate were virB11-positive.
Discussion
A unique collection of 73 C. jejuni blood culture isolates from
patients with bacteraemic infections collected during a 10-year
period all over Finland was screened for LOS locus class and
putative virulence factors. C. jejuni isolates with the potential
to sialylate LOS, which have been previously suggested to be
connected with invasiveness in vitro [7,8] and more severe
symptoms in enteritis patients [22], constituted only 23% of
the invasive bacteraemia isolates in the present study. These
TABLE 1. Bacterial multilocus sequence type (MLST) clonal complexes (CCs), putative virulence factors and patient
characteristics, according to the lipooligosaccharide (LOS) locus classes of corresponding Campylobacter jejuni bacteraemia
isolates; isolates harbouring genes needed for sialylation of LOS (LOS locus classes A, B, and C; n = 17) and those unable to
sialylate LOS (all other LOS locus classes; n = 56) are shown separately
MLST CC, putative virulence factor,
and patient characteristic
C. jejuni with LOS locus
class A, B, or C, n = 17
C. jejuni with other LOS
locus classes, n = 56 p
CC
ST-677 0 35 (32 E/O, 3 H/P) <0.0001
ST-45 0 12 (8 H/P, 4 E/O) 0.06
ST-21 10 (8 C, 2 A1) 0 <0.0001
Fucose permease gene, fucP 13 (2 A1, 3 B2, 8 C) 4 (2 H/P, 2 18df) <0.0001
c-Glutamyl transpeptidase (GGT) 1 (A1) 12 (5 E/O, 7 H/P) 0.28
Age (years), median 49 45 NS
Duration of hospitalization (days), median 5 4 0.18
Signiﬁcant underlying disease (Charlson index score of ≥1) 9 (2 A1, 2 B2, 5 C) 13 (10 E/O, 3 H/P) 0.02
NS, not signiﬁcant.
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isolates were more often detected in patients with signiﬁcant
underlying diseases, and were not more serum-resistant than
other isolates, suggesting that sialylation of LOS is not needed
for invasive C. jejuni infection.
C. jejuni shows a high level of variation in the LOS
biosynthesis loci. Locus classes A, B and C possess the genes
needed for sialylation of LOS [21,23]. In the current study, the
number of C. jejuni isolates with genes for sialylation of LOS
was very limited (17/73, 23%) as compared with cohorts of
enteritis patients, where the prevalence of such isolates has
been shown to be c. 60% [6,22,24]. This ﬁnding is especially
interesting with regard to the observation that C. jejuni strains
expressing sialylated LOS have been shown in vitro to be more
invasive in intestinal epithelial cell cultures [7,8]. Indeed, blood
culture isolates of C. jejuni would be expected to be invasive,
but, according to the ﬁndings of the current study, the in vivo
invasiveness of these particular isolates did not seem to be
based on the potential to sialylate LOS. In further support of
this, we found that isolates harbouring genes for sialylation of
LOS were signiﬁcantly more likely to be isolated from patients
with signiﬁcant underlying diseases, presumably predisposing
these particular patients to severe infections. Another impor-
tant ﬁnding was that none of the isolates of the most prevalent
CC, ST-677 CC, covering almost half of the blood isolates,
possessed genes needed for sialylation of LOS [17]. Instead
both the ST-677 CC and the other major CC, ST-45 CC, were
associated with isolates of LOS locus class E/O or H/P, in line
with earlier reports [6,25,26]. Only 15 of the 73 bacteraemia
patients had travelled abroad before the onset of the disease,
which could explain, to some extent, the present results.
However, in our recent study on faecal isolates of C. jejuni
from consecutive enteritis patients in Finland, the prevalence
of isolates capable of sialylating their LOS was 48% among the
domestic isolates [24], which is still considerably higher than
the prevalence among the blood isolates of domestic origin in
the present study (21%).
In general, resistance to complement-mediated killing in
serum is important for access of pathogens to the blood-
stream. This is also true for Campylobacter fetus, the serum
resistance of which is attributable to a proteinaceous S-layer
that is absent in C. jejuni isolates [19,27]. Although data on the
role of serum resistance in the invasiveness of C. jejuni are
scarce [17,19,28], whether some structural components of
C. jejuni could be associated with serum resistance has been
investigated. Guerry et al. [5] demonstrated that a C. jejuni
mutant with a non-sialylated LOS became more susceptible to
NHS than the wild type, indicating that sialylated LOS may
have a potential role in serum resistance. On the other hand,
Keo et al. [29] suggested that capsule expression, rather than
LOS, would be of importance for complement resistance. In
our study on non-selected C. jejuni blood isolates, susceptibility
to NHS was not attributable to the ability to sialylate LOS, as
isolates lacking genes for LOS sialylation showed a wide range
in serum susceptibility, and there was no signiﬁcant difference
between such isolates and those carrying genes for sialylation
of LOS. It remains to be investigated whether expression of
capsule polysaccharides could explain serum resistance in our
material.
None of the four putative virulence factors studied seemed
to explain the invasive character of the blood isolates. In
particular, the fucose permease gene fucP was considerably less
prevalent among the blood culture isolates in the present
study (23%) than in our earlier study on faecal isolates (49%)
[12]. This gene was previously suggested to be associated with
hyperinvasiveness in vitro [10], and with colonization ability in a
piglet infection model [15]. In the present study, we found that
fucP-positive isolates were signiﬁcantly more sensitive to
human serum than fucP-negative isolates (p 0.039), suggesting
that this gene did not contribute to the invasive phenotype of
the blood isolates. Instead, we found that fucP was associated
with the ST-21 CC, which further corroborates the conclusion
by de Haan et al. [30] that the gene is connected to particular
CCs rather than to speciﬁc hosts. In line with this, we also
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FIG. 1. Scatter plot of bacterial survival (%) in normal human serum
of Campylobacter jejuni blood isolates. Lipooligosaccharide (LOS) locus
classes A, B and C harbour genes needed for sialylation of LOS, and
other classes lack such genes. C. jejuni 11168 and a blood isolate of
C. fetus are shown as controls. Values represent means of two or
three experiments; medians are indicated by horizontal lines.
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found that production of GGT was associated with the ST-45
CC, as found in earlier studies [30,31].
In conclusion, the bacterial characteristics previously sug-
gested to be important for the invasiveness of C. jejuni, in
particular the ability to sialylate LOS, were quite uncommon in
our study group consisting of non-selected bacteraemic
C. jejuni patients, mainly without signiﬁcant underlying diseases.
This suggests that these factors had only a limited role in
C. jejuni invasion of the intestinal epithelium of those patients.
Our study emphasizes the crucial role of well-deﬁned clinical
materials in studies on bacterial virulence and understanding
human disease.
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